Similar Papers

Paper Title
Journal
Date
Author
Antibodies of the immunoglobulin a isotype to novel antigens in early axial spondyloarthritis.
Pieter Ruytinx ... Frank Vandenabeele
Frontiers in Medicine | VOL. 9
Pieter Ruytinx, et. al.Pieter Ruytinx ... Frank Vandenabeele
08 Feb 2023
Antibodies Against Three Novel Peptides in Early Axial Spondyloarthritis Patients From Two Independent Cohorts.
Dana Quaden ... Jori Liesenborgs
Arthritis & Rheumatology | VOL. 72
Dana Quaden, et. al.Dana Quaden ... Jori Liesenborgs
04 Nov 2020
AB1257 SCREENING FOR IMMUNOGLOBULIN A ANTIBODY REACTIVITY IN EARLY AXIAL SPONDYLOARTHRITIS IDENTIFIES NOVEL ANTIGENIC TARGETS
P Vandormael ... J Janssens
Annals of the Rheumatic Diseases | VOL. 79
P Vandormael, et. al.P Vandormael ... J Janssens
01 Jun 2020
FRI0363 AUTOANTIBODIES TO THREE NOVEL PEPTIDES IN EARLY AXIAL SPONDYLOARTHRITIS IN TWO INDEPENDENT COHORTS
Dana Quaden ... Piet Geusens
-
Dana Quaden, et. al.Dana Quaden ... Piet Geusens
01 Jun 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
Contents
-
Annals of the Rheumatic Diseases | VOL. 83
--
01 Dec 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.